SGS Expands Operations for its Life Science Services Business in North America
SGS has been operating its Life Science Services division in Canada since 1984, offering analytical chemistry, microbiology, and method development and validation. The existing SGS LSS facility located in the Toronto suburbs of Mississauga has been around since 1987. The new facility, also located in Mississauga, will triple the space from 15,000 square feet to 46,000 square feet. SGS LSS anticipates doubling its technical resources to handle new business opportunities. Concurrent with the move to the new facility, SGS Life Science Services R&D / QC will expand its capabilities in Canada by offering testing services for the analysis and characterization of biopharmaceuticals. The move is currently underway in phases and is expected to be complete by September.
In the US, SGS Life Science Services’ sites include a 35,000 square feet facility in Northern New Jersey. In 2006, SGS expanded its US market presence by acquiring Northview Laboratories, which added an existing facility in the Chicago suburb of Northbrook, Illinois. From this current facility in Northbrook, SGS LSS will move to a new site in Lincolnshire, Illinois, doubling the facility size from 21,500 square feet to almost 40,000 square feet. As part of the move, SGS will increase its offerings in Stability Studies and Stability Program Management. Concurrently, SGS LSS plans to double the technical staffing by the end of the first quarter of 2010. Modifications to the building are currently in progress, with move-in targeted by the end of 2009.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.